Lysyl oxidase (LOX) mRNA expression and genes of the differentiated osteoblastic phenotype are upregulated in human osteosarcoma cells by suramin.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Letters

• Publication date

  2008-06-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2008.02.008PMID 18374478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Osteopontin: regulation in tumor metastasis

  2008cited by this paper
• The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.

  2007cited by this paper
• Chemotherapy in the management of osteosarcoma and Ewing's sarcoma.

  2007cited by this paper
• The inhibition of in vivo tumorigenesis of osteosarcoma (OS)-732 cells by antisense human osteopontin RNA

  2007cited by this paper
• Understanding the mechanism of the antimitogenic activity of suramin.

  2006cited by this paper
• Hormones and growth factors regulate telomerase activity in ageing and cancer.

  2005cited by this paper
• The Propeptide Domain of Lysyl Oxidase Induces Phenotypic Reversion of Ras-transformed Cells*

  2004cited by this paper
• Lysyl Oxidase Is a Tumor Suppressor Gene Inactivated by Methylation and Loss of Heterozygosity in Human Gastric Cancers

  2004cited by this paper
• Suramin suppresses growth, alkaline-phosphatase and telomerase activity of human osteosarcoma cells in vitro.

  2003cited by this paper
• Novel stimulatory role for insulin‐like growth factor binding protein‐2 in prostate cancer cells

  2003cited by this paper
• Insulin-like growth factor I stimulates telomerase activity in prostate cancer cells.

  2003cited by this paper
• The expression of matrix metalloproteinase‐13 and osteocalcin in mouse osteoblasts is related to osteoblastic differentiation and is modulated by 1,25‐dihydroxyvitamin D3 and thyroid hormones

  2003cited by this paper
• Inhibition of the epidermal growth factor receptor suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma cells.

  2003cited by this paper
• Basic Fibroblast Growth Factor Autocrine Loop Controls Human Osteosarcoma Phenotyping and Differentiation

  2002cited by this paper
• Telomerase Immortalization of Human Myometrial Cells1

  2002cited by this paper
• Effect of IGF-I and PDGF administered in vivo on the expression of osteoblast-related genes in old rats.

  2002cited by this paper
• Nontoxic doses of suramin enhance activity of paclitaxel against lung metastases.

  2001cited by this paper
• Down-regulation of Lysyl Oxidase-induced Tumorigenic Transformation in NRK-49F Cells Characterized by Constitutive Activation of Ras Proto-oncogene*

  2001cited by this paper
• Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells.

  2001cited by this paper
• Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone

  2001cited by this paper
• Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity.

  2001cited by this paper
• Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

  2001cited by this paper
• Reconstituting Telomerase Activity Using the Telomerase Catalytic Subunit Prevents the Telomere Shorting and Replicative Senescence in Human Osteoblasts

  2001cited by this paper
• Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells.

  2001influential reference
• Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone.

  2000cited by this paper
• A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells

  2000cited by this paper
• Lysyl Oxidase Activates the Transcription Activity of Human Collagene III Promoter

  2000cited by this paper
• Tri-iodothyronine inhibits multilayer formation of the osteoblastic cell line, MC3T3-E1, by promoting apoptosis.

  1999cited by this paper
• Ethanol-induced apoptosis to stable HepG2 cell lines expressing human cytochrome P-4502E1.

  1999cited by this paper
• Suramin blocks growth-stimulatory effects of platelet-derived growth factor on malignant fibrous histiocytomas in vitro.

  1999cited by this paper
• Suramin treatment in hormone- and chemotherapy-refractory prostate cancer.

  1999cited by this paper
• Transforming growth factor beta triggers two independent-senescence programs in cancer cells.

  1999cited by this paper
• Ha-ras and N-ras regulate MAPK activity by distinct mechanisms in vivo

  1998cited by this paper
• Reduced lysyl oxidase messenger RNA levels in experimental and human prostate cancer.

  1998cited by this paper
• Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas.

  1998cited by this paper
• Expression of transforming growth factor β isoforms in osteosarcoma variants: association of tgfβ1 with high‐grade osteosarcomas

  1998cited by this paper
• The Effects of Fibroblast Growth Factor‐2 on Human Neonatal Calvaria Osteoblastic Cells Are Differentiation Stage Specific

  1998cited by this paper
• Extension of life-span by introduction of telomerase into normal human cells.

  1998cited by this paper
• Triiodothyronine, a Regulator of Osteoblastic Differentiation: Depression of Histone H4, Attenuation of c-fos/c-jun, and Induction of Osteocalcin Expression

  1997cited by this paper
• Bone Morphogenetic Protein-1: The Type I Procollagen C-Proteinase

  1996cited by this paper
• Reversion of human prostate tumorigenic growth by azatyrosine.

  1995cited by this paper
• Quantitative Polymerase Chain Reaction of Lysyl Oxidase mRNA in Malignantly Transformed Human Cell Lines Demonstrates That Their Low Lysyl Oxidase Activity Is Due to Low Quantities of Its mRNA and Low Levels of Transcription of the Respective Gene (*)

  1995cited by this paper
• The ins and outs of fibroblast growth factors.

  1994cited by this paper
• Suramin inhibits growth and transforming growth factor-beta 1 (TGF-beta 1) binding in osteosarcoma cell lines.

  1994cited by this paper
• Suramin inhibits growth and transforming growth factor-β1 (TGF-β1) binding in osteosarcoma cell lines

  1994cited by this paper
• Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3‐E1 cells

  1994cited by this paper
• Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas.

  1994cited by this paper
• Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype.

  1993cited by this paper
• Up-regulation of lysyl oxidase in spontaneous revertants of H-ras-transformed rat fibroblasts.

  1993cited by this paper
• Insulin like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth.

  1992cited by this paper
• Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine.

  1992cited by this paper
• Properties and function of lysyl oxidase.

  1991cited by this paper
• Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras.

  1990cited by this paper
• Suramin, a novel antitumor compound.

  1990cited by this paper
• Suramin in adrenal cancer: modulation of steroid hormone production, cytotoxicity in vitro, and clinical antitumor effect.

  1990cited by this paper
• Relationship of cell growth to the regulation of tissue‐specific gene expression during osteoblast differentiation

  1990cited by this paper
• Osteopontin--a possible anchor of osteoclasts to bone.

  1990cited by this paper
• Deficient production of lysyi oxidase in cultures of malignantly transformed human cells

  1986cited by this paper
• Suramin: with special reference to onchocerciasis.

  1978cited by this paper

• Molecular Cytogenetic Characterization of Synovial Sarcoma Cell Line SW982

  2021cites this paper
• Tocotrienol-rich fraction from annatto ameliorates expression of lysyl oxidase in human osteoblastic MG-63 cells

  2019cites this paper
• Lysyl Oxidase: Its Diversity in Health and Diseases

  2016cites this paper
• Inhibition of Lysyl Oxidases Improves Drug Diffusion and Increases Efficacy of Cytotoxic Treatment in 3D Tumor Models

  2015cites this paper
• Wnt and Lithium promote Gliogenesis in the adult optic nerve

  2014influential citation
• A combination treatment with DNA methyltransferase inhibitors and suramin decreases invasiveness of breast cancer cells

  2014cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2014cites this paper
• Expression of lysyl oxidase in human osteosarcoma and its clinical significance: a tumor suppressive role of LOX in human osteosarcoma cells.

  2013cites this paper
• Lysyl Oxidase Polymorphisms and Susceptibility to Osteosarcoma

  2012cites this paper
• Lysyl oxidase: a potential target for cancer therapy

  2011cites this paper
• LOX (lysyl oxidase)

  2011cites this paper
• Functional aspects of cytidine-guanosine dinucleotides and their locations in genes

  2011influential citation
• Nna1 mediates Purkinje cell dendritic development via lysyl oxidase propeptide and NF-κB signaling.

  2010cites this paper